Home
News
Editorial
MD(e)B(unker)
Related Researches
Di Bella's Foundation
1960-1969
1970-1979
1980-1989
1990-1999
2000-2009
2010-2019
2020-2029
Science news
Scientific Documentation
About us...
Biography
Bibliography
The Method
Di Bella's Method!
1998 Trial!
Media
Video Publications
News-Papers
Press
Testimonial
Testimonies
Video Gallery
Congresses
Video Testimonies
TV & C.
Case History
Lung
Lymphomas
Non-Hodgkin Lymphomas
Hodgkin Lymphomas
Mediastinum
Mesothelioma
Myeloma
Pancreas
Scientific Publications
F.A.Q.
Useful Links
User Side
Vademecum
CouponChief - Resources for Cancer Patients
Contact Us
Home page
News
Related Researches
1990-1999
Human somatostatin receptor mediated antiproliferative action evokes subtype selective cytotoxic and cytostatic signaling
Published on Tuesday, 12 August 2014
Download the complete article
About this publication
.
Search
Follow us...
Latest
Melatonin induces apoptosis in human neuroblastoma cancer cells
Melatonin induces the apoptosis and inhibits the proliferation of human gastric cancer cells via blockade of the AKT/MDM2 pathway
Melatonin inhibits growth of B16 melanoma in C57BL/6 mice
Somatostatin in oncology, the overlooked evidences
Complete objective response of neuroblastoma to biological treatment
Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in chemotherapy-pretreated patients with advanced lung adenocarcinoma and low performance status
Radio-protective effects of melatonin against irradiation-induced oxidative damage in rat peripheral blood
Melatonin May Increase Anticancer Potential of Pleiotropic Drugs
Melatonin, mitochondria, and the cancer cell
Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review)
Melatonin potentiates chemotherapy-induced cytotoxicity and apoptosis in rat pancreatic tumor cells
Melatonin reduces X-ray irradiation-induced oxidative damages in cultured human skin fibroblasts
Melatonin: reducing the toxicity and increasing the efficacy of drugs
Melatonin treatment increases the transcription of cell proliferation-related genes prior to inducing cell death in C6 glioma cells in vitro
Metabolic Anti-Cancer Effects of Melatonin: Clinically Relevant Prospects
Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone
Molecular aspects of melatonin (MLT)-mediated therapeutic effects
Molecular mechanisms of melatonin anticancer effects
Most Read
The Di Bella Method (DBM)
About melatonin - 1996
All-trans-retinoic acid and cancer
Biography
The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
Somatostatin in oncology, the overlooked evidences
Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
How effective is chemo therapy?
Complete objective response to biological therapy of plurifocal breast carcinoma
Bibliography
Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
Vademecum
Frequently Asked Questions
Declaration recommends eliminate the use of Impact factor for research evaluation
Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer